Lifecore Biomedical approves FY2026 bonus plan for executives with EBITDA, revenue targets

LIFECORE BIOMEDICAL, INC. DE

Board approved FY2026 cash bonus plan for CEO Paul Josephs (100% target), CFO Ryan Lake (60%), and CAO Thomas Salus (50%).
Bonus weighted 80% to Adjusted EBITDA and development revenue; max payout 200% of target; no bonus if minimum EBITDA unmet.
Individual performance goals and company business goals each weighted 10%.
Salus receives 125% of any bonus earned per employment agreement; all bonuses subject to clawback policy.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001005286-25-000097
form_type: 8-K
ticker: LFCR
cik: 0001005286
company_name: LIFECORE BIOMEDICAL, INC. DE
filed_at: 2025-07-18T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.114817+00:00
generated_at: 2026-05-18T05:31:34.565695+00:00
sec_items: ["5.02"]
event_type: other
sentiment: neutral
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001005286-25-000097
json_url: https://secwatch.observer/filing/0001005286-25-000097.json
markdown_url: https://secwatch.observer/filing/0001005286-25-000097.md
text_url: https://secwatch.observer/filing/0001005286-25-000097.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000097/0001005286-25-000097-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528625000097/lndc-20250715.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001005286-25-000097

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.